Dr. Fedele J. Depalma, MD

Dr. Depalma practices at Endoscopy Center of Delaware in Newark, Delaware.

Dr. Depalma's NPI, 1952549610, was assigned on February 3, 2009. Dr. Depalma graduated from Penn State College of Medicine in 2006. Dr. Depalma holds Delaware license C1-0010344.

Dr. Depalma's primary practice is Endoscopy Center of Delaware, at 1090 Old Churchmans Road, Newark, DE 19713. The practice phone is (302) 892-2710.

Dr. Depalma's primary practice is Endoscopy Center of Delaware in Newark, Delaware. Dr. Depalma is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Dr. Depalma to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Depalma practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Depalma's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Depalma is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Depalma's licenses on file in 3 states: Delaware, New Jersey and Maryland.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hepatitis c among the conditions Dr. Depalma treats.

CMS data shows 1,051 Medicare services from Dr. Depalma across 22 procedure codes in 2024, for 630 Medicare patients. Medicare paid $114,185 for them.

CMS counts 630 Medicare patients who saw Dr. Depalma in 2024. The largest group is 65 to 74, with 288 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Depalma's median patient age at 65, with 47% women.

In 2024, Dr. Depalma wrote 978 Medicare Part D claims for 296 patients. 91% of them were for generic drugs. CMS names the drug for 826 of them, across 16 drugs with 11 or more claims each, at $97,783 in total drug cost. In 2023, CMS named 841 claims across 16 drugs.

Dr. Depalma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Depalma as offering telehealth. CMS counts 400 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Depalma, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Depalma, published from 2008 to 2014. Dr. Depalma's most frequent co-authors are Naveen Anand, MD, Adib Habib Chaaya, MD and Louis A. Chaptini, MD.

CMS Open Payments shows 102 general payments to Dr. Depalma from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $859.

Dr. Depalma graduated from Penn State College of Medicine in 2006.

Dr. Depalma is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.